<Disease><Name>AROMATASE EXCESS SYNDROME (AEXS)</Name><Synonym>AROMATASE ACTIVITY, INCREASED</Synonym><OMIM><Number>139300</Number><URL>http://omim.org/entry/139300</URL></OMIM><Orphanet><Number>178346</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=178346</URL></Orphanet><Protein><Number /><URL /></Protein><ExPASy><Number /><URL /></ExPASy><Gene>15q21.2</Gene><ICD>E30.1</ICD><Summary>very rare;autosomal dominant;Overexpression of ;CYP19A1</Summary><Symptoms><symtomp><id>3333</id><symptom>bone age, advanced</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2377</id><symptom>gynecomastia</symptom><category>BODY | ENDOCRINE SYSTEM | GENERAL TOPICS</category></symtomp><symtomp><id>3689</id><symptom>hypogonadism</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>446</id><name>17-Hydroxyprogesterone</name><specimen>plasma</specimen><value /><min>1.00</min><max>93.00</max><unit>ng/dl</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>751</id><name>17-Hydroxyprogesterone</name><specimen>plasma</specimen><value /><min>50.00</min><max>1800.00</max><unit>&#181;g/dl</unit><age>premature</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>7785</id><title>Aromatase excess syndrome in a Chinese boy due to a novel duplication at 15q21.2</title><author>Tan X,</author><journal>J Pediatr Endocrinol Metab</journal><year>2019</year><book /><volume>32</volume><number>1</number><pages>85-88</pages><co_aut>et al.</co_aut></literature><literature><id>7787</id><title>Aromatase excess syndrome: a rare autosomal dominant disorder leading to pre- or peri-pubertal onset gynecomastia</title><author>Fukami M,</author><journal>Pediatr Endocrinol Rev</journal><year>2014</year><book /><volume>11</volume><number>3</number><pages>298-305</pages><co_aut>et al.</co_aut></literature><literature><id>7788</id><title>Genomic basis of aromatase excess syndrome: recombination- and replication-mediated rearrangements leading to CYP19A1 overexpression</title><author>Fukami M,</author><journal>J Clin Endocrinol Metab</journal><year>2013</year><book /><volume>98</volume><number>12</number><pages>E2013-2021</pages><co_aut>et al.</co_aut></literature><literature><id>7789</id><title>Molecular bases and phenotypic determinants of aromatase excess syndrome</title><author>Fukami M,</author><journal>Int J Endocrinol</journal><year>2012</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Shozu M, Ogata T</co_aut></literature><literature><id>7784</id><title>A potential rearrangement between CYP19 and TRPM7 genes on chromosome 15q21.2 as a cause of aromatase excess syndrome</title><author>Tiulpakov A,</author><journal>J Clin Endocrinol Metab</journal><year>2005</year><book /><volume>90</volume><number>7</number><pages>4184-4190</pages><co_aut>et al.</co_aut></literature><literature><id>7786</id><title>Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene</title><author>Shozu M,</author><journal>N Engl J Med</journal><year>2003</year><book /><volume>348</volume><number>19</number><pages>1855-1865</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>